IRadimed Corporation (IRMD) Balance Sheet

The balance sheet continues to expand, with equity rising from $76.1M in 2024Q1 to $101.7M in 2026Q2, a 33.6% increase, reflecting consistent profitability and conservative capital management. Total liabilities have stayed below $17M throughout the period, indicating no reliance on external financing. This trajectory suggests the company is funding its growth internally, which may support continued investment in the 3870 platform without balance sheet strain.

The company has eliminated all debt, with the last minor balance of $1.9M in 2024Q1 fully paid down. This debt-free status, combined with a current ratio of 9.46, indicates ample liquidity and minimal refinancing risk. The absence of leverage suggests management is prioritizing financial stability over aggressive growth, which may limit upside but provides a strong buffer against operational shocks, particularly during the 3870 launch period.

The increase in net PPE from $10.8M in 2024Q2 to $24.2M in 2026Q2 suggests investment in production capacity for the 3870 pump, aligning with the launch cycle. Goodwill and intangibles are minimal, reducing impairment risk. The asset mix is consistent with a specialized manufacturer that relies on proprietary technology rather than acquired intangibles, which may enhance earnings quality.

Equity growth is almost entirely attributable to retained earnings, reflecting a policy of reinvesting profits rather than returning capital via buybacks. The absence of dilution from share repurchases is offset by modest stock-based compensation, which totaled $807K in 2026Q2, the highest in the period. This suggests that while equity quality is high, investors should monitor SBC as a potential drag on future EPS.

With a current ratio of 9.46 and cash representing 51% of total assets, IRMD holds a substantial liquidity cushion. This buffer appears sufficient to absorb the margin compression and elevated costs associated with the 3870 launch, as evidenced by the EPS miss in 2026Q2. The strong cash position may also enable strategic investments or acquisitions, though management has not signaled such intentions.

The steady climb in deferred revenue suggests an expanding base of recurring service contracts, which may provide forward revenue visibility. This trend aligns with the razor-and-blade model, where disposables and services generate recurring cash flows. However, the absolute level remains modest relative to quarterly revenue, implying that hardware sales still dominate, and investors should monitor the mix shift toward recurring streams.